Synageva BioPharma - Ownership and Business Overview

Life ScienceCompany

Synageva BioPharma Ownership

Who owns Synageva BioPharma?

Synageva BioPharma is owned by Alexion Pharmaceuticals. It was acquired on May 6, 2015.

Synageva BioPharma Business Overview

Where is Synageva BioPharma headquartered?

Synageva BioPharma is headquartered in Lexington, Massachusetts.

What sector is Synageva BioPharma in?

Synageva BioPharma is a life science company.

When was Synageva BioPharma founded?

Synageva BioPharma was founded in 1996.

Life Science M&A Summary in 2015

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2015. The largest life science acquisition in 2015 was Allergan - which was acquired by Allergan for $70.5B.

Join Mergr to view all 293 acquisitions of life science companies in 2015, including 32 acquisitions by private equity firms, and 261 by strategics.

Synageva BioPharma Corp.

33 Hayden Avenue,
Lexington, Massachusetts 02421
United States,
(781) 357-9900
www.synageva.com

Synageva BioPharma Corp. is a biopharmaceutical company focused on the discovery, development, and commercialization of therapeutic products for patients with rare diseases. The company's pipeline consists of protein therapeutic programs for rare diseases with unmet medical need which are currently at various stages of development.


 Subscribe to unlock this and 206,305
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.